Clothes discounting was still unseasonably high, the ONS said
Organisers of the European Super League say they plan to “reshape” the controversial project after being hit by the withdrawals of the Premier League’s ‘Big Six’. Arsenal, Chelsea, Liverpool, Manchester City, Manchester United and Tottenham were all announced as being among the 12 founder members of the breakaway competition on Sunday, but on Tuesday night all of those clubs announced in quick succession that they were enacting protocol to pull out following fan protests and a huge backlash from players, managers, football authorities, leagues, pundits and governments alike. The Super League responded to those withdrawals with a statement released in the early hours of Wednesday morning in which they reiterated their belief that the existing European football structure is not fit for purpose and said that the English clubs had been “forced” to withdraw as a result of the significant pressure applied from those opposing the proposals.
Alpha Blue Ocean & Europlasma operate a rigorous value creation plan. Within this framework, Europlasma will only take the decision to expand SRF production capacity, asbestos processing or, in the near future, the processing of other hazardous waste, and to construct new units, once existing units are saturated. The decision will be based on an order book guaranteeing that the new infrastructure will be profitable right away.
He suggested the release of details of those who have received a jab and subsequently contracted Covid, been admitted to hospital or died
A cooling of the U.S. stock market's taste for plant-based meat makers has raised doubts among some investors and analysts about Impossible Foods' plans to achieve a $10 billion flotation. Impossible is seeking to go public through an initial public offering or via a merger with a blank-check company within the next 12 months, sources told Reuters this month. "It's pretty shocking when you see some of these valuations come out," said Patrick Morris, whose Eat Beyond vehicle has invested in three Canada-listed plant-based ventures.
The entrepreneur is said to have lobbied the Prime Minister after being unable to get assurance from the Treasury on overseas staff working in the UK.
Those behind the new competition have said they will consider ‘the most appropriate steps to reshape the project’.
(Bloomberg) -- Asian stocks tumbled and U.S. futures declined Wednesday as rising virus cases around the world led to renewed concern about their economic impact. Treasuries held overnight gains.An MSCI Inc. gauge of Asia-Pacific shares was on track for its biggest drop in four weeks with Japan and Hong Kong leading. Nasdaq 100 futures underperformed. S&P 500 contracts fell after the benchmark dropped for a second day, extending its slide from an all-time high, with investors showing caution ahead of the brunt of the earnings season. Treasuries held a rally that sent the 10-year yield to its lowest level in more than five weeks. The dollar edged higher. Oil prices retreated.After rising to record highs, stocks find themselves under pressure from a renewed surge in Covid-19 case around the world, raising the prospect of new lockdowns and hampering the economic recovery. Tokyo and Osaka will ask the Japanese government to declare a state of emergency. Glitches with vaccine rollouts are also raising concerns about the pace of reopenings.“The data is very mixed: on the positive side we have great vaccine rollouts that are happening and then the negative is that we have J&J being halted,” Julie Biel, portfolio manager at Kayne Anderson Rudnick, said on Bloomberg TV. “Is that going to create more vaccine hesitancy? How much of that is going to impact longer term the ability to reopen?” The end of the pandemic “is going to be much more of a push-pull, it’s going to happen in increments,” she said.The World Health Organization said coronavirus cases are rising in all regions except Europe, with India driving a surge in Asia.Elsewhere, gold cemented an advance amid the risk-off move. Bitcoin fell for the fifth time in six days.Read: Stumble in Stocks Lacks Easy Explanation for Wall Street PunditsHere are some key events to watch this week:EIA crude oil inventory report on Wednesday.European Central Bank rate decision and President Christine Lagarde briefing on Thursday.U.S. releases new home sales data Friday.These are some of the main moves in markets:StocksS&P 500 futures fell 0.1% as of 3:15 p.m. in Tokyo. The S&P 500 decreased 0.7%. The Nasdaq 100 dipped 0.7%Topix index fell 2%Australia’s S&P/ASX 200 Index dropped 0.3%Kospi index fell 1.4%Hang Seng Index lost 1.7%Shanghai Composite Index rose 0.1%Euro Stoxx 50 futures rose 0.2%CurrenciesThe yen traded at 108.03 per dollar, up 0.1%The offshore yuan was at 6.4926 per dollarThe Bloomberg Dollar Spot Index rose less than 0.1%The euro was little changed at $1.2029BondsThe yield on 10-year Treasuries held at 1.56%Australia’s 10-year bond yield fell five basis points to 1.73%CommoditiesWest Texas Intermediate crude fell 0.3% to $62.27 a barrelGold was at $1,786.34 an ounce, up 0.4%For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
A group of 12 clubs attempted to strong-arm a new breakaway competition only for those plans to collapse almost before they began
A decision could be taken any time in the first two weeks of May
‘Symbolic power of destroying house of horrors cannot be overstated,’ says attorney representing around 50 alleged victims of convicted sex offender
Killing of female polio vaccinators puts Afghan eradication campaign at risk Rise in cases feared as murders halt campaigns and leave many women too afraid to work The funeral of one of the three female polio workers who were killed in Jalalabad on 30 March 2021. Photograph: Ghulamullah Habibi/EPA
Roissy, 21 April 2021 Air France-KLM has successfully issued undated deeply subordinated notes in three tranches of €1 billion, for a total amount of €3 billion As part of its recapitalization plan announced at the launch of the capital increase announced on April 12, 2021, and completed on April 19, 2021 for an amount of €1.036 billion, the Company has issued on April 20, 2021 undated deeply subordinated notes (recorded as IFRS equity in the Company's consolidated financial statements) for a total amount of €3 billion, subscribed in full by the French State by way of set-off on claims it holds on the Company pursuant to the shareholders’ loan (the “ACC”) granted in May 2020 and fully drawn for the amount of €3 billion (the “Deeply Subordinated Notes”). This issue will be composed of three tranches with a perpetual maturity and a nominal amount of €1 billion each, with respective first redemption options (Call) at 4, 5 and 6 years and then redeemable on each interest payment date, and bearing interest at 7.00%, 7.25% and 7.50% respectively until these dates. These initial interest rates for each tranche will increase to 8.50%, 8.00% and 8.00%, respectively, on the first respective early redemption date at the option of the Company, of the relevant tranche. These interest rates will then be reset every year from April 20, 2028, on the basis of the 12-month Euribor rate plus a margin of 10.40%, it being specified that the applicable 12-month Euribor rate will not be lower than -0.45%. The Company will have the option to defer the payment of interest at its discretion, in whole or in part. Deferred interest on the Deeply Subordinated Notes will be accrued and capitalized. Payment of interest will nevertheless be mandatory notably in the event of payment of dividends or repurchase of equity securities, subject to certain customary exceptions. These Deeply Subordinated Notes may be converted by way of set-off (compensation de créances) in the context of future issuances of quasi-capital securities or capital increases. In the event of (i) a third party, acting alone or in concert, holding more than 30% of the share capital or the voting rights of Company, (ii) non-approval by the shareholders’ general meeting of a project of issuance of shares or any other securities giving right to shares of the Company, submitted by the board of directors, enabling the French State to convert in ordinary shares of the Company or any other securities giving right to shares of the Company all or part of the Deeply Subordinated Notes or (iii) implementation of an issuance of shares or other securities giving right to shares of the Company (with the exception of transactions implemented with preferential subscription rights or with priority subscription period and which may be subscribed by way of set-off (compensation de créances), transactions reserved for the French State or transactions without preferential subscription rights by way of "private placement" previously authorized by the French State), without the prior consent of the French State, the Company may redeem (a) in the event referred in (i) and (ii) above, in whole, and (b) in the event referred to in (iii) above, in whole or in part, the Deeply Subordinated Notes outstanding. Failing which the applicable interest rate shall be increased by an additional margin of 5.50% per annum from the date of occurrence of any of the events referred to in (i), (ii) or (iii). Such interest rate adjustments shall be cumulative, without exceeding 11.00% per annum. This transaction will strengthen Air France's equity by €3 billion in accordance with IFRS accounting standards, without impact on cash flow, while increasing the flexibility in its profile of debt repayment. Investor Relations Press Olivier Gall Michiel Klinkers Press office +33 1 49 89 52 59 +33 1 49 89 52 60 +33 1 41 56 56 00 firstname.lastname@example.org email@example.com Website: www.airfranceklm.com IMPORTANT INFORMATION This press release includes "forward-looking statements". All statements other than statements of historical facts included in this press release, including, without limitation, those regarding Air France-KLM’s financial position, business strategy, plans and objectives of management for future operations, are forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Air France-KLM, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding Air France-KLM’s present and future business strategies and the environment in which Air France-KLM will operate in the future. Additional factors could cause actual results, performance or achievements to differ materially. Air France-KLM expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this press release, whether as a result of new information, future developments or otherwise. This press release does not constitute an offer to sell nor a solicitation of an offer to buy, nor shall there be any sale of ordinary shares in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The distribution of this document may, in certain jurisdictions, be restricted by local legislations. Persons into whose possession this document comes are required to inform themselves about and to observe any such potential local restrictions. This press release is an advertisement and not a prospectus within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 (as amended, the “Prospectus Regulation”). Potential investors are advised to read the prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with the decision to invest in the securities. The approval of the prospectus by the AMF should not be understood as an endorsement of the securities offered or admitted to trading on a regulated market. With respect to the member states of the European Economic Area (other than France) (each a “Relevant Member State”), no action has been undertaken or will be undertaken to make an offer to the public of the securities referred to herein requiring a publication of a prospectus in any Relevant Member State. As a result, the securities may not and will not be offered in any Relevant Member State except in accordance with the exemptions set forth in Article 1 (4) of the Prospectus Regulation or under any other circumstances which do not require the publication by Air France-KLM of a prospectus pursuant to Article 3 of the Prospectus Regulation and/or to applicable regulations of that Relevant Member State. The distribution of this press release has not been made, and has not been approved, by an “authorised person” within the meaning of Article 21(1) of the Financial Services and Markets Act 2000. As a consequence, this press release is only being distributed to, and is only directed at, persons in the United Kingdom that (i) are “investment professionals” falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “Order”), (ii) are persons falling within Article 49(2)(a) to (d) (“high net worth companies, unincorporated associations, etc.”) of the Order, or (iii) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of Article 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as “Relevant Persons”). Any investment or investment activity to which this document relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. Any person who is not a Relevant Person should not act or rely on this document or any of its contents. This press release may not be published, distributed or transmitted in the United States (including its territories and dependencies). This press release does not constitute or form part of any offer of securities for sale or any solicitation to purchase or to subscribe for securities or any solicitation of sale of securities in the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) or the law of any State or other jurisdiction of the United States, and may not be offered or sold in the United States absent registration under the Securities Act or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Air France-KLM does not intend to register all or any portion of the securities in the United States under the Securities Act or to conduct a public offering of the securities in the United States. This announcement may not be published, forwarded or distributed, directly or indirectly, in the United States of America, Australia or Japan. Attachment Press release Air France-KLM has successfully issued undated deeply subordinated notes ENG
Paris, France, April 21 2021 - Atos and DreamQuark, a French start-up specializing in artificial intelligence technologies applied to the finance and insurance sectors and a member of the Atos Scaler accelerator program, are committed to developing socially responsible investment (SRI) through artificial intelligence. To this end, the two companies today announce the launch of the Sustainable Investment Brain, the first digital platform for banks and insurers that is both dedicated to SRI and compliant with the principles of transparent artificial intelligence as set out in the proposed European regulation published today. Supported by a growing interest in ESG (environmental, social and governance) issues, global sustainable fund inflows were up 88% in the fourth quarter of 2020 to more than $152bn1. Their success has since continued to build, supported by the growing demand for meaningful investments during the health crisis. The Sustainable Investment Brain accelerates this trend by combining DreamQuark's algorithmic know-how with Atos' expertise in data management and decarbonization. Based on artificial intelligence and deep learning, the solution leverages financial and extra-financial data, including accurate and standardized ESG data provided by Atos and EcoAct, an Atos Group company specialized in climate transition. Once integrated and analyzed, this data can be used to identify the investors most interested in responsible investment and to recommend the most suitable assets and investment products, taking into account their individual profile and objectives. In parallel, the platform ensures end-to-end data processing, from preparation to visualization. The attention paid to data integrity, combined with advanced management tools, allows the design, large-scale deployment and management of transparent machine learning models, respecting the European principles of autonomy, interpretability, explicability, transparency, responsibility and robustness. Additionally, the models can be manually modified to take into account company policies and regulatory obligations (e.g. the European regulation on green finance SFDR). SRI is thus becoming a real growth driver for clients, at a time when more and more private players in the finance sector are looking for a reason to exist. “Today, we find ourselves at a crossroads between major technological innovations and the need to move towards decarbonization. Now, we are proud to announce that these two areas are not mutually exclusive. The Sustainable Investment Brain solution from Atos and DreamQuark has been developed with the ambition to put technology at the service of the environment while remaining efficient and financially relevant. We thank Atos for its trust. DreamQuark has always wanted to democratize transparent Artificial Intelligence to the largest number of people, and we are sure that this is possible with Atos”, explained Nicolas Méric, founder and CEO of DreamQuark. “Digital, by enabling the automation of best practices, is the key to making responsible finance the new standard in the market. By combining data management, AI and ethics, the Sustainable Investment Brain solution from Atos and DreamQuark will enable our clients to maximize their returns, while respecting their environmental and social commitments, and taking into account regulatory changes. It is both a decarbonization and a competitiveness tool," added Isabelle Warnier, Head of Atos Scaler, Atos. “One year after the launch of our Atos Scaler acceleration program, this offer is also the proof of the effectiveness of our collaborative approach with the start-up ecosystem and we are delighted to work with DreamQuark on this project”. *** About DreamQuarkDreamQuark develops Brain, an Artificial Intelligence platform dedicated to business users and Citizen Data Scientists in banks & insurance companies. Brain delivers explainable predictions for better business decisions and is used at BNP Paribas, GAN Prévoyance and AG2R LA MONDIALE, Royal Bank of Scotland NATWEST to name a few. Building and deploying business-centric and at scale AI applications requires unique data science skills, deep business knowledge and IT expertise altogether. To remove these barriers, Brain has been developed to automate data science tasks and simplify predictive models’ industrialization. Within few clicks, business users can create powerful AI based business applications which can be easily deployed in any existing IT system through APIs. Brain leverages patented Deep Learning and advanced algorithms, which benefit from years of in-house research and development. The platform provides users with explanations for every single prediction the platform generates, empowering business users to keep full control of the technology, validate business sense and comply with regulations & ethical standards. About Atos Atos is a global leader in digital transformation with 105,000 employees and annual revenue of over € 11 billion. European number one in cybersecurity, cloud and high performance computing, the Group provides tailored end-to-end solutions for all industries in 71 countries. A pioneer in decarbonization services and products, Atos is committed to a secure and decarbonized digital for its clients. Atos operates under the brands Atos and Atos|Syntel. Atos is a SE (Societas Europaea), listed on the CAC40 Paris stock index. The purpose of Atos is to help design the future of the information space. Its expertise and services support the development of knowledge, education and research in a multicultural approach and contribute to the development of scientific and technological excellence. Across the world, the Group enables its customers and employees, and members of societies at large to live, work and develop sustainably, in a safe and secure information space. www.atos.net Press contacts:DreamQuark : Timothy Dassij et Loan Tournier | firstname.lastname@example.org | +33 6 87 18 86 52Atos : Marion Delmas | email@example.com | +33 6 37 63 91 99 1 Source : Morningstar - https://www.morningstar.com/lp/global-esg-flows Attachment PR - Atos and DreamQuark advance responsible finance with transparent artificial intelligence
Helsinn Announces the Launch of Adlumiz® (anamorelin) for the Treatment of Cancer Cachexia in Japan Lugano, Switzerland, April 21, 2021 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care and rare disease products, today announces the first launch of Adlumiz® (anamorelin) for the treatment of cancer cachexia in malignant non-small cell lung cancer, gastric cancer, pancreatic cancer and colorectal cancer in Japan, through its partner Ono Pharmaceutical. Cancer cachexia is a complex metabolic disorder syndrome, characterized by decreased body weight (especially decreased muscle mass) and anorexia associated with cancer. This condition is a common complication of cancer, that can affect up to 80% of patients with advanced cancer. It has been well documented that cancer cachexia has a significant impact on patients’ quality of life and prognosis. Adlumiz® (anamorelin), as approved by the Japanese Health Authorities, has shown efficacy in increasing body weight, muscle mass, as well as appetite in cancer cachexia patients. The risks identified in association with anamorelin are justified by the anticipated benefits that may be afforded to adult cancer patients. Helsinn recently announced the approval of Adlumiz® (anamorelin) by the Japanese Minister of Health, Labour and Welfare based on results from two clinical studies conducted in Japan in patients with cancer cachexia in the following malignant tumors: non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer. Ono Pharmaceutical, Helsinn’s license partner, has exclusive rights to develop and commercialize the product in Japan, South Korea and Taiwan. Helsinn retains full rights in the rest of the world. Development of anamorelin is ongoing internationally, through two phase III SCALA studies being conducted in the US, EU, Russia and Australia for adult patients with advanced non-small cell lung cancer for treatment of malignancy associated weight loss and anorexia. Further details on the two trials can be found on clinicaltrials.gov under: ANAM-17-20: https://clinicaltrials.gov/ct2/show/NCT03743051ANAM-17-21: https://clinicaltrials.gov/ct2/show/NCT03743064 Riccardo Braglia, Helsinn Group Vice Chairman and CEO commented: “I am proud that we are able to announce the launch of Adlumiz® (anamorelin) in Japan, following the hard work and dedication of the Helsinn team around the world. We are pleased to be able to offer this important treatment to cancer patients in the region, in close collaboration with Ono Pharmaceutical.” Sergio Cantoreggi, Helsinn Group Chief Scientific Officer commented: “We are thrilled to see the first commercial launch of Adlumiz® (anamorelin) in Japan and look forward to updating the market on the Phase III SCALA studies taking place in the US, EU, Russia and Australia which we hope will enable us to bring the treatment to more and more patients globally.” About Adlumiz® (anamorelin) Anamorelin is a selective, novel, orally active ghrelin receptor agonist. Ghrelin is an endogenous peptide primarily secreted by the stomach. Upon binding to its receptor, ghrelin stimulates multiple pathways in the positive regulation of body weight, muscle mass, appetite and metabolism. About the Helsinn Group Helsinn is a privately-owned Swiss Pharma Company which, since 1976, has been improving the lives of patients, guided by core family values of respect, integrity and quality. The Group has an extensive portfolio of marketed innovative cancer and rare disease therapies, a robust drug development pipeline and ambitions to further accelerate its growth through in-licensing and acquisitions to address unmet medical needs. Helsinn operates a unique integrated licensing business model, achieving success with long-standing partners in 190 countries, who share our values. The Group’s pharmaceutical business, (Helsinn Healthcare) is headquartered in Lugano, Switzerland with operating subsidiaries in the U.S. (Helsinn Therapeutics US) and China (Helsinn Pharmaceuticals China) which market the Group’s products directly in these countries. The Group has additional operating subsidiaries in Switzerland (Helsinn Advanced Synthesis, an active pharmaceutical ingredient manufacturer) and Ireland (Helsinn Birex Pharmaceuticals, a drug product manufacturer). 3B Future Health Fund (formerly known as Helsinn Investment Fund) was created to enhance the future of healthcare by providing funding and strategic support to innovative companies. Helsinn Group plays an active and central role in promoting social transformation in favor of people and the environment. Corporate social responsibility is at the heart of everything we do which is reinforced in the company's strategic plan by a commitment to sustainable growth. To learn more about Helsinn Group please visit www.helsinn.com About Ono Pharmaceutical Co., Ltd. Ono Pharmaceutical Co., Ltd., headquartered in Osaka, is an R&D-oriented pharmaceutical company committed to creating innovative medicines in specific areas. ONO focuses its research on the oncology, immunology, neurology and specialty research with high medical needs as priority areas for discovery and development of innovative medicines. For further information, please visit the company’s website at www.ono-pharma.com/. Helsinn Group Media Contact: Paola Bonvicini Group Head of Communication Lugano, Switzerland Tel.: +41 91-985-21-21 Info-HHC@helsinn.com For more information, please visit www.helsinn.com and follow us on Twitter, LinkedIn and Vimeo
WISekey has joined forces with Jacob & Co to NFT the Astronomia Sky the epitome of 21st century haute horlogerie and a globally recognized symbol of Jacob & Co watchmaking expertise.
Brussels, 21 April 2021, 08:30 CEST - According to Belgian transparency legislation (Law of May 2, 2007), BlackRock Inc. (55 East 52nd Street, New York, NY, 10055, U.S.A.) recently sent to Solvay the following transparency notifications indicating that it crossed the threshold of 3%. Here is a summary of the moves: Date on which the threshold was crossedVoting rights after the transactionEquivalent financial instruments after the transactionTotalApril 15, 20213.03%0.17%3.20%April 16, 20212.90%0.23%3.13% The latest notification, dated April 20, 2021, contains the following information: Reason for the notification: acquisition or disposal of voting securities or voting rightsNotified by: BlackRock Inc. (55 East 52nd Street, New York, NY, 10055, U.S.A.)Date on which the threshold is crossed: April 16, 2021Threshold of direct voting rights crossed: 3% downwardsDenominator: 105,876,416Additional information: The disclosure obligation arose due to voting rights attached to shares for BlackRock, Inc. going below 3%. Transparency notifications are available on the Investor Relations Section of Solvay's website. Attachments Solvay_2021-04-16_Issuer_signed Solvay_2021-04-15_Issuer_signed 20210421_transparency declaration Blackrock-EN
Accordo tra il Parlamento Europeo e il Consiglio Ue sulla legge sul clima. Nella notte a Bruxelles i negoziatori hanno chiuso nel trilogo l'intesa, che dà la priorità alla riduzione delle emissioni climalteranti nel raggiungere l'obiettivo di ridurle del 55% entro il 2030 rispetto ai livelli del 1990, anziché alla rimozione delle stesse (vengono 'catturate' e stoccate per lunghi periodi di tempo). Previsto anche un volume più elevato di depositi di carbonio (carbon sink) entro il 2030. Per la presidente della Commissione Ursula von der Leyen, "la legge sul clima mette l'Ue su un percorso verde per una generazione. E il nostro impegno vincolante per i nostri figli e i nostri nipoti". Viene anche creato un un advisory board scientifico composto da 15 scienziati, con mandato quadriennale (non più di 2 per Stato membro) che farà proposte e monitorerà gli effetti del processo di adattamento 'verde' dell'economia europea. La Commissione dovrebbe poi fissare più avanti un altro obiettivo vincolante per il 2040, oltre a quello del 2030, per raggiungere la neutralità climatica entro il 2050. L'esecutivo Ue inoltre si impegnerà con i settori economici che scelgano di stilare volontariamente delle roadmap per raggiungere la neutralità climatica al 2050.
Stock Split split list Zurich - 21 April 2021 - 21Shares AG, the Swiss pioneering fintech ETP issuer is delighted to announce that it has completed its Corporate Action event consisting of a stock split for 10 of its ETPs. The event marks a first in the crypto asset ETP segment. The event was triggered to broaden the accessibility by employing forward share splits of the majority of its ETPs for which the underlying cryptoassets have rallied by more than 50% in the last 4 months. The board of directors of 21Shares carefully monitors the health of the products to ensure that they are performing as expected as well as constantly monitoring developments in crypto assets. Employing a stock split enables the firm to keep the ETPs to trade at prices within efficient and accessible ranges. The stock split went into effect on April 12th and lowered the ETP’s per security net asset value and increased the number of securities outstanding (see attached chart). “This corporate event marked an important milestone in the life of the company and demonstrates the strong performance of the underlying asset class as well as the ability of the firm to deliver ETP stock spilts at an early stage of its growth.” Said Laurent Kssis, 21Shares Managing Director, Global Head of ETP. “As crypto assets continue to gain traction and huge interest from institutional investors, splitting the ETPs has achieved 2 key things, firstly tightening the bid/ask spreads for the benefit of investors and secondly lowering the price point to allow smaller minimum investment as the price of crypto assets continues to reach record highs.” concluded Hany Rashwan, CEO of 21Shares. Tickers, ISINs and WKNs (Kuerzel) of the products remained unchanged. If any investors have questions about their holdings and the impact of the stock split, they should contact ETP@21shares.com or visit the website on www.21shares.com. About 21Shares Founded in 2018, 21Shares AG ( formerly Amun) is the leading crypto fintech issuer of ETP in Switzerland. It aims to make investing in crypto assets as easy as buying shares using your conventional broker or bank. Investors can invest in cryptocurrencies using a conventional ETP structure (or tracker) easily, with total confidence, security and cost-effectively thanks to the 21Shares suite of ETPs now composed of 12 Crypto ETPs : the 21Shares Crypto Basket Index ETP (HODL:SW), 21Shares Bitcoin (ABTC:SW | 21XB:GY), 21Shares Ethereum (AETH:SW | 21XE GY), 21Shares XRP (AXRP:SW | 21XX:GR), 21Shares Bitcoin Cash ETP (ABCH:SW | 21XC:GY), 21Shares Binance ETP (ABNB:SW), 21Shares Tezos ETP (AXTZ:SW), 21shares Bitcoin Suisse ETP (ABBA:SW), 21Shares Bitwise 10 ETP (KEYS:SW), Sygnum Platform Winners Index ETP (MOON:SW), 21Shares Short Bitcoin ETP (SBTC:SW | 21XS:GY), 21Shares Polkadot ETP (ADOT:SW | PDOT:GR). The entire suite is listed on a regulated framework on the official market of Deutsche Boerse, SIX Swiss Exchange, BX Swiss, the Wiener Boerse and MTF on Börse Stuttgart in CHF, USD, GBP and EUR respectively. Incorporated and headquartered in the canton of Zug, with offices in Zurich and New York, the company has launched several world firsts, including the first listed crypto basket index (HODL) ETP in November 2018 and currently manages assets of 1.5 billion US Dollars. In order to always be up to date, 21Shares AG has established an in-house research team. Press Contact Laurent Kssis +41 44 260 8660 press@21Shares.com Disclaimer This document and the information contained herein are not for distribution in or into (directly or indirectly) the United States, Canada, Australia or Japan or any other jurisdiction in which the distribution or release would be unlawful. This document does not constitute an offer of securities for sale in or into the United States, Canada, Australia or Japan. This document does not constitute an offer to sell, or a solicitation of an offer to purchase, any securities in the United States. The securities of 21Shares AG to which these materials relate have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There will not be a public offering of securities in the United States.This document is only being distributed to and is only directed at: (i) to investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (ii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as "relevant persons"); or (iv) persons who fall within Article 43(2) of the Order, including existing members and creditors of the Company or (v) any other persons to whom this document can be lawfully distributed in circumstances where section 21(1) of the FSMA does not apply. The Securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents. In any EEA Member State (other than the Austria, Belgium, Denmark, Finland, France, Germany, Great Britain, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Spain and Sweden) that has implemented the Prospectus Regulation (EU) 2017/1129, together with any applicable implementing measures in any Member State, the "Prospectus Regulation") this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Regulation. Exclusively for potential investors in Austria, Belgium, Denmark, Finland, France, Germany, Great Britain, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Spain and Sweden the 2019 Base Prospectus (EU) is made available on the Issuer’s website under www.21Shares.com. The approval of the 2019 Base Prospectus (EU) should not be understood as an endorsement by the SFSA of the securities offered or admitted to trading on a regulated market. Eligible potential investors should read the 2019 Base Prospectus (EU) and the relevant Final Terms before making an investment decision in order to understand the potential risks associated with the decision to invest in the securities. You are about to purchase a product that is not simple and may be difficult to understand. This document is not an offer to sell or a solicitation of an offer to buy or subscribe for securities of 21Shares AG. Neither this document nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. This document constitutes advertisement within the meaning of the Swiss Financial Services Act and not a prospectus. Copies of the current Base Prospectus dated 13 November 2020 are available free of charge from the website of the Issuer. Subject to applicable securities laws, the Base Prospectus and the final terms of any product mentioned herein can be obtained from 21Shares AG on the website. Copies of this document may not be sent to jurisdictions, or distributed in or sent from jurisdictions, in which this is barred or prohibited by law. The information contained herein does not constitute an offer to sell or the solicitation of an offer to buy, in any jurisdiction in which such offer or solicitation would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any jurisdiction. Attachment Stock Split
Sydney, April 21, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies: Antipa Minerals Ltd (ASX:AZY) has received binding commitments for a non-underwritten placement to raise $22 million and will undertake a share purchase plan (SPP) of up to $3 million, resulting in a total capital raising of up to $25 million. Click hereEmyria Ltd (ASX:EMD) has received firm commitments from sophisticated and strategic investors in a well supported $5 million placement. Click hereImugene Ltd (ASX:IMU) (OTCMKTS:IUGNF) has achieved a clinical milestone for its HER-Vaxx cancer immunotherapy in Phase 2 gastric cancer clinical trial. Click hereAlta Zinc Ltd (ASX:AZI) (FRA:8EE) continues to be encouraged by exploration at Gorno Project in northern Italy with multiple high-grade zinc and lead intersections, along with silver, received from drilling the Ponente area of the Gorno Mine. Click hereMusgrave Minerals Ltd (ASX:MGV) (OTCMKTS:MGVMF) (FRA:6MU) has received further strong results at its flagship Cue Gold Project in Western Australia with regional aircore drilling at Target 14 within the new gold corridor west of Lena returning up to 12 metres at 8.7 g/t from 66 metres. Click hereMatador Mining Ltd (ASX:MZZ) (OTCMKTS:MZZMF) (FRA:7MR) has generated multiple new priority geophysical gold targets near the Window Glass Hill (WGH) deposit within the Cape Ray Gold Project in Newfoundland, Canada. Click hereEcoGraf Ltd’s (ASX:EGR) proposed Kwinana Battery Anode Materials Facility has been granted major project status, which recognises the importance of the development and supports the Australian Government’s Critical Minerals Strategy and Western Australia’s Future Battery Industry Strategy. Click here About Proactive With six offices on three continents and a team of experienced business journalists and broadcasters, Proactive works with innovative growth companies quoted on the world’s major stock exchanges, helping executives engage intelligently with investors. Proactive’ s platform delivers the right message to the right audience, digitally and in real time, leveraging a range of media, investment research, digital investor targeting and website development services to support over 1,000 fast-growing companies globally. Proactive’s network reaches over 12 million engaged private, professional and institutional investors looking for opportunities. • Our written and video content is published on Proactive sites that collectively attract up to 10 million views per month.• We syndicate our content to hundreds of mainstream and specialist news sites that expand our reach into networks that can be difficult for press releases to penetrate.• We custom build corporate websites from the ground up, empowering clients and their brands with a modern online presence and the latest insight on effective SEO strategy.• Our news coverage ranks high on the world’s most popular search platforms, and we can further amplify online presence and outreach with sophisticated digital investor targeting.• We help the world understand what makes companies stand out from the crowd with in-depth investment research from a team of experienced analysts. For more information on how Proactive can help you make a difference, email us at firstname.lastname@example.org